In cervical cytology screening laboratories quality control and insurance are governed by international recommendations. The authors reevaluated 10% (2451 cases) of their negatively labelled 24501 cervicovaginal smears using the rapid (30 seconds') microscopic evaluation method. During the rescreening they diagnosed 3 (0,1%) false negative cases. Out of these 2 proved to be H SIL (severe intraepithelial squamous lesion; P4) whereas 1 proved to be an AGC (rather - atypical neoplastic columnar cells; P4). They give a short summary of the cases. They conclude that reduction in the rate of false cervical cytology screening diagnoses would depend upon the yearly repeated complex gynaecological examination as well as upon the institution of the quality control recommendations.
|Number of pages||4|
|Journal||Magyar Noorvosok Lapja|
|Publication status||Published - Dec 1 2005|
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynaecology